These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34521889)

  • 1. CXCL9 as a key biomarker of vitiligo activity and prediction of the success of cultured melanocyte transplantation.
    Lin F; Hu W; Xu W; Zhou M; Xu AE
    Sci Rep; 2021 Sep; 11(1):18298. PubMed ID: 34521889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity.
    Strassner JP; Rashighi M; Ahmed Refat M; Richmond JM; Harris JE
    J Am Acad Dermatol; 2017 May; 76(5):847-855.e5. PubMed ID: 28259440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blister roof grafting, cultured melanocytes transplantation and non-cultured epidermal cell suspension transplantation in treating stable vitiligo: A mutual self-control study.
    Bao H; Hong W; Fu L; Wei X; Qian G; Xu A
    J Dermatolog Treat; 2015; 26(6):571-4. PubMed ID: 26247842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.
    Liu LY; Strassner JP; Refat MA; Harris JE; King BA
    J Am Acad Dermatol; 2017 Oct; 77(4):675-682.e1. PubMed ID: 28823882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Repigmentation with Cultured Melanocyte Transplantation (CMT) Compared with Non-Cultured Epidermal Cell Transplantation in Vitiligo at 12th Week Reveals Better Repigmentation with CMT.
    Verma G; Varkhande SR; Kar HK; Rani R
    J Invest Dermatol; 2015 Oct; 135(10):2533-2535. PubMed ID: 25950826
    [No Abstract]   [Full Text] [Related]  

  • 7. Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo.
    Yamaguchi Y; Peeva E; Duca ED; Facheris P; Bar J; Shore R; Cox LA; Sloan A; Thaçi D; Ganesan A; Han G; Ezzedine K; Ye Z; Guttman-Yassky E
    Arch Dermatol Res; 2024 Jul; 316(7):478. PubMed ID: 39023568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo.
    Zhang DM; Hong WS; Fu LF; Wei XD; Xu AE
    Dermatol Surg; 2014 Apr; 40(4):420-6. PubMed ID: 24446755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.
    Rashighi M; Agarwal P; Richmond JM; Harris TH; Dresser K; Su MW; Zhou Y; Deng A; Hunter CA; Luster AD; Harris JE
    Sci Transl Med; 2014 Feb; 6(223):223ra23. PubMed ID: 24523323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Treatment of Stable Vitiligo by Low-Density Cultured Autologous Melanocyte Transplantation Combined With Narrowband Ultraviolet B Therapy.
    Yao L; Liu Y; Song Y; Zhong S; Li S
    Dermatol Surg; 2017 Oct; 43(10):1281-1287. PubMed ID: 28445194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repigmentation of vitiligo-associated leukotrichia after autologous, non-cultured melanocyte-keratinocyte transplantation.
    Al Jasser MI; Ghwish B; Al Issa A; Mulekar SV
    Int J Dermatol; 2013 Nov; 52(11):1383-6. PubMed ID: 23834588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous noncultured melanocyte transplantation for stable vitiligo: can suspending autologous melanocytes in the patients' own serum improve repigmentation and patient satisfaction?
    Sahni K; Parsad D; Kanwar AJ; Mehta SD
    Dermatol Surg; 2011 Feb; 37(2):176-82. PubMed ID: 21269348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation.
    Hong WS; Hu DN; Qian GP; McCormick SA; Xu AE
    Br J Dermatol; 2011 Sep; 165(3):520-5. PubMed ID: 21564070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Treatment of Vitiligo on the Scalp of a 9-Year-Old Girl Using Autologous Cultured Pure Melanocyte Transplantation.
    Wu XG; Xu AE
    Pediatr Dermatol; 2017 Jan; 34(1):e22-e23. PubMed ID: 27813161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation.
    Falabella R; Arrunategui A; Barona MI; Alzate A
    J Am Acad Dermatol; 1995 Feb; 32(2 Pt 1):228-32. PubMed ID: 7829707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target area treatment ratio of varied lesions in the cultured pure melanocyte transplantation repigmentation of vitiligo: A retrospective study.
    Lin F; Wang Y; Zheng Y; Hong W; Fu L; Zhou M; Xu A
    J Dermatol; 2024 Jun; ():. PubMed ID: 38895831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: A 30-month follow-up.
    Orouji Z; Bajouri A; Ghasemi M; Mohammadi P; Fallah N; Shahbazi A; Rezvani M; Vaezirad F; Khalajasadi Z; Alizadeh A; Taghiabadi E; Dashtbozorgi S; Aghdami R; Hosseini SE; Bahahrvand H; Shafieyan S; Aghdami N
    J Dermatol Sci; 2018 Jan; 89(1):52-59. PubMed ID: 29103774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population.
    Toossi P; Shahidi-Dadras M; Mahmoudi Rad M; Fesharaki RJ
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1182-6. PubMed ID: 21214632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas.
    Silpa-Archa N; Griffith JL; Huggins RH; Henderson MD; Kerr HA; Jacobsen G; Mulekar SV; Lim HW; Hamzavi IH
    J Am Acad Dermatol; 2017 Aug; 77(2):318-327. PubMed ID: 28502377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of autologous melanocyte transfer in treatment of stable vitiligo.
    Pandya V; Parmar KS; Shah BJ; Bilimoria FE
    Indian J Dermatol Venereol Leprol; 2005; 71(6):393-7. PubMed ID: 16394479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.